Gómez-Mahiques M, Lopez-Mateu C, Gil-Terrón FJ, Montosa-I-Micó V, Svensson SF, Mendoza Mireles EE, Vik-Mo EO, Emblem KE, Balañà-Quintero C, Puig J, Alenda C, Martinez-Saez E, Martínez-Ricarte F, Quirós-Martí M, Quilis-Quesada V, García-Gómez JM, Fuster-Garcia E (2026)
Automated Delineation of Putative Non-Contrast-Enhancing Tumor in Glioblastoma: Prognostic Insights
Neuro Oncol (in press)
DOI 10.1093/neuonc/noag042, PubMed 41741374

Mendoza Mireles EE, Blakstad H, Server A, Leske H, Skaga E, Aarhus M, Brandal P, Helseth E, Nayak L, Rønning PA, Vik-Mo EO (2026)
Extent of resection and perioperative neurological status as prognostic markers in glioblastoma: a population-based study
J Neurooncol, 177 (1)
DOI 10.1007/s11060-026-05481-y, PubMed 41733819

Allega MF, Deshmukh R, Hillinger T, Akhmetshina A, Oudin A, Bielik R, Soloviev D, Villar VH, Ackermann T, Bourmeau G, Chahal SK, Stevenson KH, Nixon C, Shaw R, Morrison GM, Chalmers AJ, Pollard SM, Lund-Johansen M, Bjerkvig R, Seano G, Niclou SP, Vik-Mo EO, Lewis DY, Sumpton D, Tardito S (2026)
Steroid-dependent metabolic rewiring reveals novel therapeutic and imaging approaches for glioblastoma
Sci Adv, 12 (4), eadx6539
DOI 10.1126/sciadv.adx6539, PubMed 41576167